Drug Discovery

Patient advocacy group
#Clinical trial design #Clinical trials #Decentralised clinical trials #Drug development #Patient centricity #Rare disease

Recruiting and retaining patients for successful drug development

Craig Stevens, Senior Patient Engagement Specialist, and Amanda Henkel, VP, Strategy from MEDiSTRAVA (an Inizio Company), delve into the challenges and opportunities that surround clinical trial design for rare diseases. The drug development process requires collaboration at all stages, and is particularly important in… Read More

#Exclusive Content

#Cancer research #Clinical trial design #Clinical trials #Drug discovery #Gene therapy #Oncology

Podcast: Key stories from the drug discovery industry

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Perhaps most interestingly this week, after previous caution over in vivo… Read More

#News

#Biopharmaceuticals #Cell and gene therapy #Covid-19 #Drug development

Overcoming inefficiencies to improve access to cell and gene therapy 

The cell and gene therapy (CGT) landscape has grown significantly in the past year. Between the 24 therapies already approved by the FDA1 and a marked increase in clinical trials, widespread accessibility to precision medicine feels within reach. Lauren Collison, PhD, Senior VP, Operations & Site Head, KBI Biopharma, reflects.  … Read More

#Exclusive Content #Opinion

#Cancer research #Clinical trial design #Clinical trials #Drug discovery #Gene therapy #Oncology

This week in drug discovery (6-10 March)

News round-up for 6-10 March by DDW Digital Content Editor Diana Spencer.  Perhaps most interestingly this week, after previous caution over in vivo gene therapy trials, the FDA has given the go ahead to Intellia Therapeutics to study NTLA-2002 in hereditary angioedema (HAE).  There have been several… Read More

#News

African medical researchers
#Africa #AI / data analytics / healthtech / informatics #Collaboration #Collaborative Drug Discovery (CDD) #Data management #Drug discovery

Informatics resource advances drug discovery in Africa

African researchers are now able to access Collaborative Drug Discovery’s CDD Vault resource for neglected disease drug discovery collaborations.  Collaborative Drug Discovery (CDD), a scientific informatics company that provides data management and analysis solutions, is offering free subscriptions to CDD Vault for select academic teams of scientists… Read More

#News

#Drug development #Drug discovery #Imaging #Magnetic Resonance Imaging (MRI) #Pharmaceuticals #Technology

eBook: Imaging and drug discovery

A new eBook is now available for download. This latest eBook sponsored by Bethyl Laboratories/Fortis Life Science features expert opinions on how imaging technologies are informing drug discovery and bringing more insight into treating diseases. Download this exclusive eBook to learn more about: The importance of imaging… Read More

#News

#AI #Biobanking #Drug discovery #Genomics #Personalised medicine

Drug discovery hotspots: Focus on Qatar

DDW Editor Reece Armstrong takes a look at Qatar’s drug discovery and life sciences market, exploring how the country is utilising innovative technologies in its approach to healthcare.   The Middle East represents one of the world’s most lucrative markets for pharmaceuticals. Along with Africa, the Middle East stands as… Read More

#Exclusive Content #Market Reports

#Cancer research #Cancer treatment #CAR-T #Cell therapy #Drug discovery #Epigenetics #Immunotherapy #Oncology

New episode of the DDW Highlights podcast available

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  As well as providing extensive coverage of the … Read More

#News

Start-up business
#BioInnovation Institute #Drug discovery #Investment #Life sciences #Start-ups

Institiute gives a boost to five new life science start-ups

Five drug discovery companies have entered the BioInnovation Institute’s (BII) Venture Lab acceleration programme for early-stage companies as part of a cohort of ten new members.  The 12-month Venture Lab programme is designed to support start-up companies with business acceleration, scientific, and team development, and provides a… Read More

#News #Start-up Zone

Kim and Bethan Nanion
#ApconiX #Cardiovascular disease #Drug discovery #Podcast #Screening

Podcast: The benefits of early ion channel screening

The latest sponsored DDW Sitting Down With podcast is now available. It features Dr Michael Morton, Director and Co-founder, ApconiX, and Dr Kimberly Rockley of ApconiX, who discuss the benefits of early ion channel screening. The podcast covers the hERG ion channel and its importance in cardiac safety screening… Read More

#News

Kim and Bethan Nanion
#ApconiX #Cardiovascular disease #Drug discovery #Podcast #Screening

The benefits of early ion channel screening

The latest sponsored DDW Sitting Down With podcast features Dr Michael Morton, Director and Co-founder, ApconiX, and Dr Kimberly Rockley of ApconiX who discuss the benefits of early ion channel screening. The podcast covers the hERG ion channel and its importance in cardiac safety screening in drug discovery. … Read More

#News

#Cancer research #Cancer treatment #CAR-T #Cell therapy #Drug discovery #Epigenetics #Immunotherapy #Oncology

This week in drug discovery (27 February – 3 March)

News round-up for 27 February – 3 March by DDW Digital Content Editor Diana Spencer.  As well as providing extensive coverage of the SLAS2023 meeting in San Diego and Rare Disease Day, DDW has also reported on a… Read More

#News

Laboratory research
#Cancer research #Collaboration #Drug discovery #Oncology #Partnership #Target identification #Target validation

Partners from UK and Singapore agree cancer drug discovery deal

Cancer Research Horizons and Singapore’s Experimental Drug Development Centre (EDDC) have announced a five-year strategic partnership to accelerate the translation of cancer research into improved treatments for cancer patients.   The international alliance will focus on leveraging the complementary capabilities, platforms and technologies from both partners, to accelerate… Read More

#Cancer Research #News

#Antivirals #Drug development #Drug discovery #Henipavirus #Investment

Millions invested in antiviral medicines for future pandemics 

The partners in the Pandemic Antiviral Discovery (PAD) initiative have announced grants totalling more than $26 million for 14 research projects aimed at facilitating early-stage development of drugs to treat henipavirus infection and disease in humans.  These grants mark the majority of the first investments to come… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Connected chemistry: Choose the most promising drug candidates

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

Neuron and antibodies
#AI / data analytics / healthtech / informatics #Antibodies #Antiverse #Drug discovery #Funding #Investment #Machine learning

AI company raises $3m to develop antibodies targeting GPCRs

Antiverse has successfully identified functional antibody clusters targeting two G-protein-coupled receptors (GPCRs), both displaying versatile binding profiles and nanomolar affinity.  The company has raised $3 million in funding, which will enable in-house development of the antibodies showing the highest affinity blocking function. The antibodies were identified using Antiverse’s proprietary… Read More

#News